European Commission grants orphan designation for Lundbeck's asedebart
Pulnovo Medical commences enrolment in PULSE-LHD IDE clinical trial
Nuvation Bio's safusidenib granted FDA Fast Track Designation for IDH1-mutant glioma treatment
Maverix Medical's Narwhal Cryo System receives FDA 510(k) clearance
Lupin's VISUfarma signs European licensing deal for presbyopia therapy YUVEZZI
Aqua Medical treats second type 2 diabetes patient in IDE trial of investigational PIMA procedure
Harbour BioMed IND for HBM7004 approved by China's NMPA
Hansa Biopharma reports first Australian transplant using Idefirix